NEO
Diagnostics & Research · Healthcare
Board Member
Equibles does not estimate personal net worth.
Anthony P. Zook was last confirmed as Board Member at Neogenomics Inc (NEO) in a filing dated April 8, 2025. Neogenomics Inc reported in an 8-K filed May 22, 2026 that Anthony P. Zook was appointed member of the Board of Directors, effective May 21, 2026. Neogenomics Inc reported in an 8-K filed May 27, 2025 that Anthony P. Zook was appointed member of the Board of Directors, effective May 22, 2025. Anthony P. Zook has spoken on 1 earnings call across 1 company, most recently for Neogenomics Inc on July 29, 2025. The companies whose calls Anthony P. Zook spoke on are classified in the Healthcare sector.
“The election of Lynn A. Tetrault, Dr. Marjorie C. Green, Dr. Neil Gunn, Stephen M. Kanovsky, Michael A. Kelly, John P. Kenny, David B. Perez, Felicia Williams and Anthony P. Zook to serve as members of the Board of Directors until the next succeeding annual meeting of stockholders or until his or her successor has been duly elected and qualified.”
“The election of Lynn A. Tetrault, Elizabeth A. Floegel, Dr. Neil Gunn, Dr. Alison L. Hannah, Stephen M. Kanovsky, Michael A. Kelly, David B. Perez, Felicia Williams and Anthony P. Zook to serve as members of the Board of Directors until the next succeeding annual meeting of stockholders or until his or her successor has been duly elected and qualified.”
“I'm pleased to lead this call having now completed my first quarter as CEO. Since becoming CEO in April, I've engaged with the business, including sales, operations, and R&D, and reexamined our strategic initiatives and financial targets from a more in-depth perspective than I could as a director.”
Start not stated–2025-04-08
Last confirmed by a filing; no departure on record
NEO
Diagnostics & Research · Healthcare
Board Member